Abstracts tagged "Systemic sclerosis"

Abstract Number: 125 • 2012 ACR/ARHP Annual Meeting
Borderline Right Ventricular Involvement in Patients with Systemic Sclerosis without Pulmonary Hypertension
Luna Gargani¹, Piotr Gosciniak², Cosimo Bruni³, Serena Guiducci³, Silvia Bellando Randone³, Lorenza Pratali¹, Gergely Agoston⁴, Alberto Moggi Pignone⁵, Albert Varga⁴, Rosa Sicari¹, Eugenio Picano¹ and Marco Matucci Cerinic⁶, ¹Institute of Clinical Physiology, National Research Council, Pisa, Italy, ²WSZ, Department of Cardiology, Szczecin, Poland, ³Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, ⁴University of Szeged, Faculty of Medicine, 2nd Dept of Internal Medicine & Cardiology Center, Szeged, Hungary, ⁵University of Florence, Department of Medicine, Division of Rheumatology, Florence, Italy, ⁶Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy
Background/Purpose: Cardiac dysfunction in systemic sclerosis (SSc) is associated with poor prognosis. Right ventricular involvement is tipically associated to pulmonary hypertension (PH) in these patients.…
Abstract Number: 94 • 2012 ACR/ARHP Annual Meeting
Medical Costs and Health Care Resource Use in Patients with Systemic Sclerosis in an Insured Population
Daniel Furst¹, Ancilla W. Fernandes², Serban R. Iorga³, Warren Greth⁴ and Tim Bancroft³, ¹Div of Rheumatology, UCLA Medical School, Los Angeles, CA, ²MedImmune, LLC, Gaithersburg, MD, ³OptumInsight, Eden Prairie, MN, ⁴Clinical Development, MedImmune, LLC, Gaithersburg, MD
Background/Purpose: Systemic sclerosis (SSc) is a chronic connective tissue disease affecting the skin and/or internal organs. Data on US economic burden of SSc is scant…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].